Indoleamine 2,3-dioxygenase (IDO) is frequently expressed in stromal cells of Hodgkin lymphoma and is associated with adverse clinical features: a retrospective cohort study

BACKGROUND: Regulation of tumor microenvironment is closely involved in the prognosis of Hodgkin lymphoma (HL). Indoleamine 2,3-dioxygenase (IDO) is an enzyme acting as immune modulator through suppression of T-cell immunity. This study aims to investigate role of IDO in the microenvironment of HL....

Descripción completa

Detalles Bibliográficos
Autores principales: Choe, Ji-Young, Yun, Ji Yun, Jeon, Yoon Kyoung, Kim, Se Hoon, Park, Gyeongsin, Huh, Joo Ryoung, Oh, Sohee, Kim, Ji Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026588/
https://www.ncbi.nlm.nih.gov/pubmed/24886161
http://dx.doi.org/10.1186/1471-2407-14-335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026588/
https://www.ncbi.nlm.nih.gov/pubmed/24886161
http://dx.doi.org/10.1186/1471-2407-14-335

Ejemplares similares